March 6, 2009 – VectraCor Inc. submitted its 510(k) application to the FDA in December for a new technology to derive 22-lead ECG function from only five electrodes
March 6, 2009 - Transoma Medical Inc.’s Sleuth AT wireless, automated implantable cardiac monitoring system was implanted in its first U.S. patient on March 2 at the Ohio State University Medical Center.
Researchers at the Section of Cardiology, Department of Medicine, University of Chicago Hospitals said their findings, published in the March 1 issue of the American Journal of Cardiology, Vol. 103, Issue 5, suggest SPECT perfusion imaging should be conducted on patients who have abnormal heart rate recovery (HRR) on routine exercise treadmill testing.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 6, 2009 - Atritech Inc. will release PROTECT AF trial results on WATCHMAN LAA closure technology comparing the device to the current standard of care, warfarin therapy, in patients with non-valvular atrial fibrillation.
March 6, 2009 – New research published in the March edition of the HeartRhythm Journal reveals that black and Hispanic patients who were eligible for cardiac resynchronization therapy with defibrillator (CRT-D) were less likely to receive therapy than eligible white patients.
March 6, 2009 - American College of Cardiology’s (ACC) President W. Douglas Weaver, M.D., participated in yesterday’s White House Summit on Health Care and released the following comments:
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 6, 2009 – At the ECR congress, Barco unveiled an upgraded version of the Nio Color 3MP diagnostic display system, featuring a high-bright LCD panel.
March 5, 2009 - In the first six-year follow-up of a pivotal study of any drug-eluting stent, the clinical benefits of the CYPHER Sirolimus-eluting Coronary Stent compared to a bare-metal stent (BMS) were sustained according to data presented at the Cardiovascular Revascularization Therapies conference.
March 5, 2009 - During the Best Peer Practice "Achieve Measurable Results Through CVIS" Webinar, attendees will learn how to use CVIS data to support quality initiatives and provide instant feedback on performance.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
March 5, 2009 - Bristol-Myers Squibb Company yesterday said it is collaborating with Nissan Chemical Industries Ltd. and Teijin Pharma Ltd.
March 5, 2009 - CorMatrix Cardiovascular Inc., developer of extracellular matrix (ECM Technology) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, announced the first implant in Europe of the CorMatrix ECM Technology in a patient undergoing cardiac surgery.
March 5, 2009 - TomTec is showcasing its brand-new CardioArena multimodality workstation for Cardio PACS during the upcoming ECR conference in Vienna, Austria. The CardioArena platform is a commercially available solution for 2D, 3D, and 4D imaging data. It serves multimodality platform for all major medical imaging modalities such as ultrasound, MRI and cathlab.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
March 5, 2009 - Prescient Medical Inc. announced it completed enrollment in February of 30 patients in the first phase of its first-in-human clinical trial for the vProtect Luminal Shield, conducted at the Corbic Research Institute in Colombia.
March 5, 2009 - Patients with chronic kidney disease who also suffer from atrial fibrillation (AF) are at increased risk for stroke, according to a new study by Kaiser Permanente researchers in the current online issue of Circulation.
March 5, 2009 - Reducing the frequency and severity of disabling migraines is crucial for quality of life and a new study, published in the February 2009 issue of JACC: Cardiovascular Interventions, finds significant improvement of migraines following catheter-based closure of patent foramen ovale (PFO).